ScholarIQanswers from OpenAlex & ORCID
Thomas Kræmer
ResearcherPublications, citations & collaboration network
Thomas Kræmer is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Thomas Kræmer have?
ScholarIQindexed works
Thomas Kræmer has 372 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Thomas Kræmer have?
ScholarIQcitation count
Thomas Kræmer has 10,388 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Thomas Kræmer?
ScholarIQh-index
Thomas Kræmer has an h-index of 55 in OpenAlex.
What is the i10-index of Thomas Kræmer?
ScholarIQi10-index
Thomas Kræmer has an i10-index of 213 in OpenAlex.
What is the ORCID of Thomas Kræmer?
ScholarIQorcid
The ORCID for Thomas Kræmer is on the source record.
What is the OpenAlex record for Thomas Kræmer?
ScholarIQopenalex
The OpenAlex for Thomas Kræmer is on the source record.
What are the most-cited papers on Thomas Kræmer?
ScholarIQmost cited works
Titanium dioxide nanoparticles exacerbate DSS-induced colitis: role of the NLRP3 inflammasome
Pedro A. Ruiz, Belén Morón, Helen M. Becker, Silvia Lang, Kirstin Atrott, Marianne R. Spalinger, Michael Scharl, Kacper A. Wojtal, Anne Fischbeck-Terhalle, Isabelle Frey‐Wagner, Martin Hausmann, Thomas Kræmer, Gerhard Rogler
Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke
Bruce Campbell, Peter Mitchell, Leonid Churilov, Nawaf Yassi, Timothy Kleinig, Richard Dowling, Bernard Yan, Steven Bush, Vincent Thijs, Rebecca Scroop, Marion Simpson, Mark Brooks, Hamed Asadi, Teddy Y. Wu, Darshan Shah, Tissa Wijeratne, Henry Zhao, Fana Alemseged, Felix Ng, Peter Bailey, Henry E. Rice, Laetitia de Villiers, Helen M. Dewey, Philip Choi, Helen Brown, Kendal Redmond, David Leggett, John Fink, Wayne Collecutt, Thomas Kræmer, Martín Krause, Dennis Cordato, Deborah Field, Henry Ma, Bill O’Brien, Benjamin Clissold, Ferdinand Miteff, Anna Clissold, Geoffrey Cloud, Leslie Bolitho, Luke Bonavia, Arup Bhattacharya, A. A. Wright, Abul Mamun, Fintan O’Rourke, John Worthington, Andrew Wong, Christopher Levi, Christopher F. Bladin, Gagan Sharma, Patricia Desmond, Mark Parsons, Geoffrey A. Donnan, Stephen M. Davis, EXTEND-IA TNK Part 2 investigators, James A. Taylor, Craig Kurunawai, Edmund Cheong, Anna Balabanski, Michael J. Waters, Jackson Harvey, Lavenia Cagi, Nicholas Chia, Anthony Khoo, Roy Drew, Jennifer Cranefield, Thomas J. Oxley, Cameron Williams, Edrich Rodrigues, Patrick Salvaris, Angela Dos Santos, Jo-Lyn Ng, Skye Coote, Carolyn Beltrame, Elizabeth A. Mackey, Kanaga Lagma, Amy McDonald, David M. Jackson, Jessica Tsoleridis, Lauren Pesavento, Ashu Jhamb, Amy Brodtmann, Alexandra Warwick, Bronwyn Coulton, Dennis Young, Justin Whitley, Carol Bendall, Hans T.H. Tu, Sherisse Celestino, Essie Low, Arman Sabet, Sachin Mishra, Berzenn Urbi, Tanya Frost, Jessie Chen, Siew Kar Chen, Melissa Y Tang, Kara Nowak, Rodrigo Pereira Martins, Channa Senanayake
Treatment of Refractory Status Epilepticus with Propofol: Clinical and Pharmacokinetic Findings
Mark M. Stecker, Thomas Kræmer, Eric C. Raps, Rosemary O'Meeghan, Eugene L. Dulaney, Debra J. Skaar
Toxicokinetics of Amphetamines: Metabolism and Toxicokinetic Data of Designer Drugs, Amphetamine, Methamphetamine, and Their N-Alkyl Derivatives
Thomas Kræmer, Hans H. Maurer
Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs (‘Ecstasy’)
Hans H. Maurer, Joerg Bickeboeller-Friedrich, Thomas Kræmer, Frank T. Peters